8-K - Jazz Pharmaceuticals plc | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Other Events. On November 17, 2025, Jazz Pharmaceuticals plc issued a press release announcing positive top-line results from the Phase 3 HERIZON-GEA-01 trial

Other Event

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated November 17, 2025. 104 104 Cover Page Interactive Data Fil

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1